Our research group focuses on developing translational nanomedicine, gene therapy, and stem cell therapy for treatment of neurological disorders through a unique combination of neuroscience, stem cell biology, cancer biology, and emerging nanotechnology. The ultimate goal of our research is to establish more effective methods to treat patients with these diseases.
For more information about our research, please check the Research section.
Jiangbing Zhou, PhD.
7/2012- Assistant Professor, Yale University
2011-2012 Associate Research Scientist, Yale University
2008-2011 Postdoctoral Associate, Yale University
2008 PhD., Johns Hopkins University
2001 MS, Tsinghua University
1998 B.E. East China University of Science and Technology
Current and Past Funding Support
We thank the following for their current and past support of our research.
NIH/NINDS, NIH/NCI, NIH/NIBIB, NIH/NCATS, Connecticut Innovations, American Cancer Society, American Heart Association, American Brain Tumor Association, Patrys Limited, Matthew Larson Foundation, TheCureStartNow Foundation, Swebilius Foundation, VABC Foundation, and B*CURED foundation.